LIVE
Cold, Flu, COVID-19, or RSV: How to Distinguish Respiratory Infections by Early Symptoms Evening Cravings: How a Balanced Dinner Helps Prevent Nighttime Snacking Butternut Squash, Sweet Potatoes, and Beans: Three Autumn Foods to Lower Cholesterol and Blood Pressure Should You Wash Hair or Body First? Experts Explain the Right Shower Routine The Ferritin Connection: Why Iron Deficiency Leads to Thinning Hair Scientists Prove Human Heart Can Regenerate Cells After Heart Attack How Foot Thermoregulation Impacts Sleep Quality and Who Should Be Cautious Understanding Xerostomia: Causes of Dry Mouth and Practical Ways to Manage It Morning Facial Swelling: Causes, Remedies, and When to Seek Medical Advice Why under-eye bags form and when eye creams fail to work Cold, Flu, COVID-19, or RSV: How to Distinguish Respiratory Infections by Early Symptoms Evening Cravings: How a Balanced Dinner Helps Prevent Nighttime Snacking Butternut Squash, Sweet Potatoes, and Beans: Three Autumn Foods to Lower Cholesterol and Blood Pressure Should You Wash Hair or Body First? Experts Explain the Right Shower Routine The Ferritin Connection: Why Iron Deficiency Leads to Thinning Hair Scientists Prove Human Heart Can Regenerate Cells After Heart Attack How Foot Thermoregulation Impacts Sleep Quality and Who Should Be Cautious Understanding Xerostomia: Causes of Dry Mouth and Practical Ways to Manage It Morning Facial Swelling: Causes, Remedies, and When to Seek Medical Advice Why under-eye bags form and when eye creams fail to work

New COVID-19 Variant PJ.2.1: Current Understanding of Spread and Symptoms

🔬 Дослідження 1 min read 👁 0

The WHO is monitoring the new PJ.2.1 coronavirus variant spreading globally and preparing to update vaccine formulations.

New COVID-19 Variant PJ.2.1: Current Understanding of Spread and Symptoms🔬Дослідження

Photo: ТСН: Здоров'я

Key points

  • Detection of PJ.2.1 in the US, Canada, and Europe
  • Symptoms resemble flu and common cold
  • WHO vaccine update scheduled for 2026

A new coronavirus strain, identified as PJ.2.1, has been detected across North America and Europe. The World Health Organization (WHO) is actively monitoring the situation and has requested researchers to provide data on this variant to better understand its characteristics.

The clinical presentation of PJ.2.1 does not show unique symptoms that would distinguish it from previous SARS-CoV-2 variants or seasonal influenza. Patients typically report fever, cough, runny nose, sore throat, muscle aches, and significant fatigue. Due to the overlap in symptoms with other respiratory infections, experts emphasize that laboratory testing is essential for an accurate diagnosis.

Currently, there is no clinical evidence suggesting that PJ.2.1 causes more severe disease compared to earlier variants. However, the WHO intends to review vaccine compositions in December 2026 to address emerging mutations. Meanwhile, monitoring continues in Ukraine regarding another subvariant known as "Cicada," which presents with similar COVID-19 symptoms.

Source ТСН: Здоров'я — tsn.ua/zdorovya/svitom-shyrytsia-novyy-vyd-koronavirusu-z-chym-yoho-moz… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.